Today, cutting edge non-invasive multimodal imaging technologies and strategies are indispensable in pre-clinical small animal research. With the introduction of advanced multimodal imaging platforms and novel probes, researchers are now able to combine data sets across imaging technologies easier and faster than ever before. This enables them to better quantify and understand mechanism of disease progression at the tissue and cellular level, and ultimately, advances the discovery and development of new biomarkers, drugs and therapeutics.

In this half day seminar we will explore the work of two independent research scientists from Baylor College of Medicine and the University of Notre Dame who specialize in small animal research using high resolution optical/X-ray, nuclear and/or CT systems. They will discuss the role and importance of using diverse imaging modalities within their research, including fusion techniques and strategies, to simultaneously study biodistribution and efficacy of therapeutic candidates, new probe development and validation, as well as designing target-specific theragnostics and monitoring therapeutic efficacy in real time.

In addition, a presentation by scientists from Carestream Molecular Imaging will highlight recent advances in new and novel PET and SPECT detector technologies, multimodal in vitro and ex vivo techniqes, and a new platform architecture that combines high resolution optical (luminescence, fluorescence, radioisotopic) and X-ray imaging modalities in one system, along with unprecedented system configuration flexibility.